Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This Bitcoin-focused microcap is building a treasury strategy centered on accumulating BTC (click to learn more) Laser Photonics Reports Full Year Total Net Sales Increase of 144% in Q4 2025 Financial Results (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Purple Biotech Ltd PPBT

Healthcare Biotechnology
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PPBT)

Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform

GlobeNewswire March 25, 2026

Purple Biotech Regains Compliance with Nasdaq

GlobeNewswire March 17, 2026

Purple Biotech Announces CEO Transition

GlobeNewswire March 13, 2026

Purple Biotech Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire March 13, 2026

Purple Biotech Announces Plan to Implement ADS Ratio Change

GlobeNewswire February 25, 2026

Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240

GlobeNewswire January 7, 2026

Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025

GlobeNewswire December 11, 2025

Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress

GlobeNewswire December 4, 2025

Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire November 14, 2025
View More News ››

Opinion & Analysis (NDAQ:PPBT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PPBT)

Buy buddy buy.

Otherwise FOMO for you guys out there today anyway
coolfooldumbguy - July 24, 2025

Using technical analysis for this stock.

It should be going up this morning,so good luck to all shareholders out there
coolfooldumbguy - April 30, 2025

Buy buddy buy because it's taking off this morning.

This stock is signalling a big uptrend for shareholders today
coolfooldumbguy - April 30, 2025

Up $5 or 150%

Wow thats huge for holders, this doesn't happen very often
Coins2paper - December 2, 2024

PPBT....I only had 3 scalps on this today.....LoL

Now in PB mode post H.O.D....currently tapping downtrend support at $9.05....has to hold and rally or its a slippery slope to next...
Iseneschal - December 2, 2024

KTOV To The Moon 🚀

Still holding since 47 cents. Waiting for KTOV and Merck Partnership.
TheGreatBull888 - June 30, 2020
View more Bullboard ››

Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications ...
View More »

Podcasts